Select Publications
Book Chapters
2019, 'Preparation of a dithiol-reactive probe for PET imaging of cell death', in Functional disulphide bonds : methods and protocols, pp. 295 - 304, http://dx.doi.org/10.1007/978-1-4939-9187-7_19
,2014, 'Visualization of proteins and cells using dithiol-reactive metal complexes', in Gasser G (ed.), Inorganic Chemical Biology: Principles, Techniques and Applications, John Wiley & Sons, Ltd, pp. 215 - 232, http://dx.doi.org/10.1002/9781118682975.ch7
,2003, 'PET Imaging in Lung Cancer', in Nuclear Medicine In Radiological Diagnosis, Taylor & Francis, pp. 617 - 632
,Journal articles
2024, 'A rare pediatric case of FDG-avid synovial herniation pits', Radiology Case Reports, 19, pp. 5662 - 5664, http://dx.doi.org/10.1016/j.radcr.2024.08.105
,2024, 'Cerebral hypometabolism in a pediatric patient with clinically resolved posterior reversible encephalopathy syndrome', Radiology Case Reports, 19, pp. 3653 - 3655, http://dx.doi.org/10.1016/j.radcr.2024.05.058
,2024, 'Clinical Images: Crowned dens syndrome detected on 18F-fludeoxyglucose–positron emission tomography/computed tomography during investigation for giant cell arteritis', Arthritis and Rheumatology, 76, pp. 664 - 665, http://dx.doi.org/10.1002/art.42777
,2024, 'Clinical Image: Brachial arteritis on positron emission tomography/computed tomography in acute eosinophilic granulomatosis with polyangiitis', ACR Open Rheumatology, http://dx.doi.org/10.1002/acr2.11741
,2024, 'Editorial for “Added Value of [18F]PSMA-1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management”', Journal of Magnetic Resonance Imaging, http://dx.doi.org/10.1002/jmri.29426
,2024, 'FDG PET/CT in large vessel vasculitis', Journal of Medical Imaging and Radiation Oncology, http://dx.doi.org/10.1111/1754-9485.13800
,2023, 'Incidental finding of tall cell variant papillary thyroid carcinoma on prostate-specific membrane antigen PET CT scan', Journal of Medical Imaging and Radiation Oncology, 67, pp. 753 - 755, http://dx.doi.org/10.1111/1754-9485.13595
,2023, 'Imaging of cell death in malignancy: Targeting pathways or phenotypes?', Nuclear Medicine and Biology, 124-125, http://dx.doi.org/10.1016/j.nucmedbio.2023.108380
,2022, 'A first-in-human study of [68Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death', European Journal of Nuclear Medicine and Molecular Imaging, 49, pp. 4037 - 4047, http://dx.doi.org/10.1007/s00259-022-05880-z
,2022, 'Preclinical Assessment of [68Ga]Ga-Cell Death Indicator (CDI): A Novel hsp90 Ligand for Positron Emission Tomography of Cell Death', Current Radiopharmaceuticals, 15, pp. 184 - 193, http://dx.doi.org/10.2174/1874471014666211122100646
,2021, 'Clinical Images: Pulmonary Arteritis in Clinically Occult Aneurysmal Giant Cell Arteritis', ACR Open Rheumatology, 3, pp. 356, http://dx.doi.org/10.1002/acr2.11249
,2021, 'Novel 5-point 18-FDG-PET/CT visual scoring system for assessing treatment response in patients with oesophageal or gastro-oesophageal junction carcinoma', Journal of Medical Imaging and Radiation Oncology, 65, pp. 23 - 37, http://dx.doi.org/10.1111/1754-9485.13110
,2020, 'Influence of X-ray computed tomography (CT) exposure and reconstruction parameters on positron emission tomography (PET) quantitation', EJNMMI Physics, 7, http://dx.doi.org/10.1186/s40658-020-00331-w
,2020, 'Influence of X ray computed tomography (CT) exposure and reconstruction parameters on positron emission tomography (PET) quantitation.', , http://dx.doi.org/10.21203/rs.3.rs-35526/v2
,2020, 'Influence of X Ray Computed Tomography (CT) Exposure and Reconstruction Parameters on Positron Emission Tomography (PET) Quantitation', , http://dx.doi.org/10.21203/rs.3.rs-35526/v1
,2020, 'Biodistribution and imaging of an hsp90 ligand labelled with 111In and 67Ga for imaging of cell death', EJNMMI Research, 10, http://dx.doi.org/10.1186/s13550-020-0590-x
,2020, 'Concordant PET/CT and ICG positive lymph nodes in endometrial cancer: a case of mistaken identity.', J Surg Case Rep, 2020, pp. rjz377, http://dx.doi.org/10.1093/jscr/rjz377
,2016, 'Application of novel quantitative techniques for fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer', Asia-Pacific Journal of Clinical Oncology, 12, pp. 349 - 358, http://dx.doi.org/10.1111/ajco.12587
,2016, '18F-FDG PET-CT performed before and during radiation therapy of head and neck squamous cell carcinoma: Are they independent or complementary to each other?', Journal of Medical Imaging and Radiation Oncology, 60, pp. 433 - 440, http://dx.doi.org/10.1111/1754-9485.12439
,2016, 'Prognostic Value of 2-[18F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria', Clinical Oncology, http://dx.doi.org/10.1016/j.clon.2015.12.026
,2015, 'Prognostic role of metabolic parameters of 18F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma', European Journal of Nuclear Medicine and Molecular Imaging, http://dx.doi.org/10.1007/s00259-015-3104-8
,2015, 'Prognostic role of metabolic parameters of 18F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma', European Journal of Nuclear Medicine and Molecular Imaging, 42, pp. 1984 - 1994, http://dx.doi.org/10.1007/s00259-015-3104-8
,2015, 'PO-118: Prognostic role of FDG-PET metabolic parameters during radiotherapy for head and neck squamous cell carcinoma', Radiotherapy and Oncology, 114, pp. 58 - 58, http://dx.doi.org/10.1016/s0167-8140(15)34878-7
,2012, 'Impact of FDG-PET on lung cancer delineation for radiotherapy', Journal of medical imaging & radiation oncology, 56, pp. 195 - 203, http://dx.doi.org/10.1111/j.1754-9485.2012.02356.x
,2012, 'Workflow and radiation safety implications of 18 FDG PET/CT scans for radiotherapy planning', Journal of Nuclear Medicine Technology, 40, pp. 175 - 177, http://dx.doi.org/10.2967/jnmt.111.099440
,2011, 'Positron emission tomography and colorectal cancer', Critical Reviews in Oncology/Hematology, 77, pp. 30 - 47, http://dx.doi.org/10.1016/j.critrevonc.2010.04.011
,2011, 'Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer', Radiotherapy and Oncology, 101, pp. 284 - 290, http://dx.doi.org/10.1016/j.radonc.2011.06.030
,2011, 'Positron emission tomography in non-medullary thyroid cancers', ANZ Journal of Surgery, 81, pp. 116 - 124, http://dx.doi.org/10.1111/j.1445-2197.2010.05538.x
,2011, 'The prevalence and clinical significance of 18F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma', Hematological Oncology, 29, pp. 67 - 74, http://dx.doi.org/10.1002/hon.955
,2010, 'Positron emission tomography: current status and future challenges', Internal Medicine Journal, 40, pp. 19 - 29, http://dx.doi.org/10.1111/j.1445-5994.2009.02072.x
,2010, 'The registration of diagnostic versus planning fluorodeoxyglucose positron emission tomography/computed tomography in radiotherapy planning for non-small cell lung cancer', Clin Oncol (R Coll Radiol), 22, pp. 554 - 560, http://dx.doi.org/10.1016/j.clon.2010.05.014
,2009, 'Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: Results of a multicentre prospective study', European Journal of Nuclear Medicine and Molecular Imaging, 36, pp. 354 - 361, http://dx.doi.org/10.1007/s00259-008-0959-y
,2009, 'Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: Results of a multicentre prospective study', European Journal of Nuclear Medicine and Molecular Imaging, 36, pp. 347 - 353, http://dx.doi.org/10.1007/s00259-008-0958-z
,2008, 'The utility of FDG-PET in the preoperative staging of esophageal cancer', Diseases of the Esophagus, 21, pp. 389 - 394, http://dx.doi.org/10.1111/j.1442-2050.2007.00802.x
,2008, 'A clinical comparison between traditional planar V/Q images and planar images generated from SPECT V/Q scintigraphy', Nuclear Medicine Communications, 29, pp. 323 - 330, http://dx.doi.org/10.1097/MNM.0b013e3282f4a240
,2008, 'Comparison of pinhole and SPECT 99mTc-MIBI imaging in primary hyperparathyroidism', Nuclear Medicine Communications, 29, pp. 949 - 955, http://dx.doi.org/10.1097/MNM.0b013e328309789e
,2008, 'Guidelines for imaging in cutaneous melanoma', Nuclear Medicine Communications, 29, pp. 877 - 879, http://dx.doi.org/10.1097/MNM.0b013e3283043a0c
,2008, 'Imaging in cutaneous melanoma', Nuclear Medicine Communications, 29, pp. 847 - 876, http://dx.doi.org/10.1097/MNM.0b013e32830439fb
,2007, 'Breast implant mimicking pericardial effusion in a cancer patient undergoing gated heart pool radionuclide study', Medical Journal of Australia, 187, pp. 465 - 466, http://dx.doi.org/10.5694/j.1326-5377.2007.tb01358.x
,2007, 'Additional benefit of SPECT/CT in bone scanning of metastatic renal cell carcinoma', Clinical Nuclear Medicine, 32, pp. 411 - 414, http://dx.doi.org/10.1097/01.rlu.0000259641.90922.1f
,2007, 'Treatment response in liver metastases following 90Y SIR-spheres: An evaluation with PET', Hepato-Gastroenterology, 54, pp. 910 - 912
,2006, 'Spect/ct imaging using a spiral ct scanner for anatomical localization: impact on diagnostic accuracy and reporter confidence in clinical practice', Nuclear Medicine Communications, 27, pp. 977 - 987, http://dx.doi.org/10.1097/01.mnm.0000243372.26507.e7
,2006, 'Unusual case of lymphoma', Internal Medicine Journal, 36, pp. 468 - 469
,2004, 'The role of FDG-PET in the management of non-small cell lung carcinoma', Annals of the Academy of Medicine Singapore, 33, pp. 166 - 174
,2003, '', Clinical Nuclear Medicine, 28, pp. 171 - 175, http://dx.doi.org/10.1097/00003072-200303000-00001
,2003, 'F-18 FDG Positron Emission Tomography and Benign Fractures', Clinical Nuclear Medicine, 28, pp. 171 - 175, http://dx.doi.org/10.1097/00003072-200303000-00001
,2002, 'Clinical applications of PET in oncology', CME Cancer Medicine, 1, pp. 48 - 55
,